Dolby Laboratories (NYSE:DLB) CAO Sells $21,644.91 in Stock

Dolby Laboratories (NYSE:DLB) CAO Ryan Nicholson sold 357 shares of Dolby Laboratories stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $60.63, for a total value of $21,644.91. Following the completion of the transaction, the chief accounting officer owned 36,984 shares of the company’s stock, valued at approximately $2,242,339.92. This trade represents a 0.96% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Dolby Laboratories Price Performance

DLB opened at $61.70 on Friday. The business has a fifty day moving average price of $52.82 and a 200 day moving average price of $58.49. Dolby Laboratories has a 12 month low of $48.26 and a 12 month high of $75.66. The stock has a market capitalization of $5.78 billion, a price-to-earnings ratio of 26.26 and a beta of 0.80.

Dolby Laboratories (NYSE:DLB) last released its earnings results on Thursday, July 30th. The electronics maker reported $0.69 earnings per share for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02. The firm had revenue of $305.00 million for the quarter, compared to analyst estimates of $311.96 million. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The business’s quarterly revenue was down 3.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.78 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. On average, research analysts anticipate that Dolby Laboratories will post 3.24 earnings per share for the current year.

Dolby Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 19th. Stockholders of record on Tuesday, August 11th will be issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Tuesday, August 11th. Dolby Laboratories’s dividend payout ratio (DPR) is presently 61.28%.

Dolby Laboratories announced that its board has initiated a stock buyback program on Thursday, July 30th that permits the company to buyback $350.00 million in shares. This buyback authorization permits the electronics maker to repurchase up to 7% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s management believes its shares are undervalued.

Hedge Funds Weigh In On Dolby Laboratories

A number of institutional investors have recently modified their holdings of DLB. Royal Bank of Canada increased its stake in Dolby Laboratories by 3.5% in the first quarter. Royal Bank of Canada now owns 68,367 shares of the electronics maker’s stock valued at $5,491,000 after purchasing an additional 2,298 shares during the period. Goldman Sachs Group Inc. raised its holdings in shares of Dolby Laboratories by 218.8% in the first quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker’s stock valued at $20,043,000 after buying an additional 171,288 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Dolby Laboratories by 5.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 238,216 shares of the electronics maker’s stock worth $19,131,000 after buying an additional 12,598 shares during the period. Focus Partners Wealth acquired a new stake in shares of Dolby Laboratories during the first quarter worth about $390,000. Finally, EverSource Wealth Advisors LLC grew its holdings in shares of Dolby Laboratories by 273.3% during the second quarter. EverSource Wealth Advisors LLC now owns 2,598 shares of the electronics maker’s stock worth $193,000 after buying an additional 1,902 shares during the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on DLB. Barrington Research restated an “outperform” rating and set a $90.00 target price on shares of Dolby Laboratories in a research note on Monday, June 15th. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a report on Wednesday, June 24th. Rosenblatt Securities restated a “buy” rating and set a $85.00 price objective on shares of Dolby Laboratories in a research report on Friday, July 31st. Finally, Wall Street Zen cut shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $90.75.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.